FINN Partners Tapped to Lead Global Communications for AD/PD Conference

The appointment aims to elevate the visibility of the conference, which serves as a nexus for clinicians and scientists working in translational neuroscience. By leveraging its specialized brain health practice, FINN Partners will manage media relations and stakeholder engagement to bolster delegate participation and highlight breakthroughs across the event’s 12 scientific tracks.

Dr. Abraham Fisher, co-founder and president of AD/PD, noted that the collaboration is designed to amplify the conference's mission to bridge the gap between laboratory research and patient care. The agency intends to utilize its "One FINN" model to coordinate efforts across its global network, focusing on driving international abstract submissions and showcasing milestones in neurodegenerative science. This move aligns with FINN's existing portfolio of biotech and pharmaceutical clients, solidifying its position as a central player in health communications.